The Beginning of the End for Bananas?

Already reeling from a 20-year losing battle with a devastating disease, the banana variety eaten in the United States is now threatened by a new—but old—enemy.

Written byDan Koeppel
| 4 min read
bananas race 4

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, VALERII EVLAKHOV

Our standard supermarket banana, a variety called Cavendish, may be at the brink of disaster. Chosen for its resistance to a fungal pathogen that wiped out its predecessor, the Gros Michel banana, the popular fruit has long battled a related fungus, which has all but devastated the banana industry in certain parts of the world. Now, it appears the Cavendish variety is facing a new threat—the very same fungal disease that drove Gros Michels off the market.

Cavendish bananas account for about 45 percent of the fruit's global crop, with an annual export value of US$8.5 billion, according to the United Nations Food and Agriculture Organization. It was chosen to replace the original Gros Michel banana after a deadly fungal infection, known as Panama disease (Fusarium oxysporum f. sp. Cubense), wiped out much of the world’s banana crop in the first half of the 20th ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies